PP2A contributes to HIF1-α downregulation and the inhibition of vascularization (elevated VEGF levels) in order to reduce the metabolic demand of GBM and pancreatic cancer cells [131,155]. This evidence concerns the gene PTPA and pancreatic neoplasm.